Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Current Leases (2021 - 2025)

BioAtla's Current Leases history spans 5 years, with the latest figure at $1.4 million for Q4 2025.

  • For Q4 2025, Current Leases rose 70.69% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $1.4 million, up 70.69%, while the annual FY2025 figure was $1.4 million, 70.69% up from the prior year.
  • Current Leases reached $1.4 million in Q4 2025 per BCAB's latest filing, up from $1.2 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $1.7 million in Q2 2024 to a low of $554000.0 in Q1 2025.
  • Average Current Leases over 5 years is $1.3 million, with a median of $1.5 million recorded in 2022.
  • The largest YoY upside for Current Leases was 70.69% in 2025 against a maximum downside of 63.29% in 2025.
  • A 5-year view of Current Leases shows it stood at $1.4 million in 2021, then increased by 9.5% to $1.5 million in 2022, then increased by 6.77% to $1.6 million in 2023, then crashed by 48.52% to $836000.0 in 2024, then skyrocketed by 70.69% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Current Leases are $1.4 million (Q4 2025), $1.2 million (Q3 2025), and $805000.0 (Q2 2025).